GLP-3 (RT) is a synthetic multi-receptor peptide designed to interact with:

-Glucagon-like peptide-1 (GLP-1), 

-Glucose dependent insulinotropic polypeptide (GIP),

 -Glucagon receptor pathways. 

It is produced via solid-phase peptide synthesis and supplied in a stable, lyophilized format suitable for controlled laboratory research environments.